EFFECTIVENESS AND COST-EFFECTIVENESS OF TRIPLE THERAPY WITH TELAPREVIR AND BOCEPREVIR FOR CHRONIC HEPATITIS C: A DECISION ANALYSIS FROM THE PERSPECTIVE OF THE BRAZILIAN PUBLIC HEALTH SYSTEM

被引：0
|
作者：
Borba, H. H. [1 ]
Rochau, U. [2 ]
Wiens, A. [1 ]
Sroczynski, G. [2 ]
Siebert, U. [3 ]
Pontarolo, R. [1 ]
机构：
[1] Univ Fed Parana, Curitiba, Parana, Brazil
[2] UMIT Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & HTA, Dept Publ Hlth Hlth Serv Res & HTA, Hall In Tirol, Austria
[3] UMIT Univ Hlth Sci Med Informat & Technol, Dept Publ Hlth Hlth Serv Res & Hlth Technol Asses, Hall In Tirol, Austria
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.2627
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI9
引用
收藏
页码：A883 / A883
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness and Price of Aripiprazole for Schizophrenia in the Brazilian Public Health System
    Santos, Andre Soares
    Micaela de Souza Noronha, Kenya Valeria
    Andrade, Monica Viegas
    Ruas, Cristina Mariano
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2020, 23 (01) : 27 - 37
  • [32] Cost-effectiveness of treatment for chronic hepatitis C
    Koff, RS
    JOURNAL OF HEPATOLOGY, 1999, 31 : 255 - 258
  • [33] COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS-C VIRUS INFECTION IN VENEZUELA
    Garcia Marti, S.
    Alcaraz, A.
    Valanzasca, P.
    Garay, O. U.
    McMullen, M.
    Rey Ares, L.
    Obando, C. A.
    Caporale, J.
    VALUE IN HEALTH, 2013, 16 (07) : A714 - A714
  • [34] Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir
    Mauss, Stefan
    Eisenbach, Christoph
    Heyne, Renate
    Moog, Gero
    Lutz, Thomas
    Naumann, Uwe
    Geissler, Michael
    Pape, Stefan
    Mordeja, Matthias
    Herold, Christoph
    Simon, Karl-Georg
    Isernhagen, Konrad
    Alshuth, Ulrich
    Buggisch, Peter
    Hueppe, Dietrich
    HEPATOLOGY, 2013, 58 : 1112A - 1112A
  • [35] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir
    Loustaud-Ratti, Veronique
    Carrier, Paul
    Vong, Chanlina
    Essig, Marie
    HEPATOLOGY, 2014, 59 (06) : 2426 - 2426
  • [36] COST-EFFECTIVENESS ANALYSIS OF TOFACITINIB IN THE TREATMENT OF ULCERATIVE COLITIS IN THE PERSPECTIVE OF BRAZILIAN PUBLIC HEALTHCARE SYSTEM
    Holanda, P.
    Salgado De Santana, C.
    Senna, T.
    Carmo, L.
    Alexandre, R. F.
    VALUE IN HEALTH, 2021, 24 : S96 - S96
  • [37] Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C
    Buti, M
    Casado, MA
    Fosbrook, L
    Wong, JB
    Esteban, R
    JOURNAL OF HEPATOLOGY, 2000, 33 (04) : 651 - 658
  • [38] Cost-effectiveness of combination therapy for relapsers with chronic hepatitis C.
    Buti, M
    Casado, MA
    Fosbrook, L
    Esteban, R
    HEPATOLOGY, 1999, 30 (04) : 197A - 197A
  • [39] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir
    Mauss, Stefan
    Hueppe, Dietrich
    Alshuth, Ulrich
    HEPATOLOGY, 2014, 59 (01) : 46 - 48
  • [40] COST-EFFECTIVENESS ANALYSIS OF TRANSTHYRETIN-ASSOCIATED AMYLOID CARDIOMYOPATHY FROM THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE
    Sebastiao, M.
    Ferreira, P.
    Senna, T.
    Alexandre, R. F.
    Almeida, P.
    VALUE IN HEALTH, 2023, 26 (06) : S156 - S156
12345